Skip to main content
. 2022 Feb 3;107(10):2295–2303. doi: 10.3324/haematol.2021.279520

Table 3.

Non-dose-limiting non-hematologic toxicities related to protocol therapy and observed in >10% of evaluable patients (n=15).

graphic file with name 1072295.tab3.jpg